BD Phoenix酵母鉴定板与Remel RapID Yeast Plus系统用于酵母鉴定的比较评估
Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification.
作者信息
Grant Michelle L, Parajuli Shobha, Deleon-Gonsalves Raquel, Potula Raghava, Truant Allan L
机构信息
Departments of Pathology and Laboratory Medicine, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA.
Clinical Microbiology, Immunology and Virology Laboratories, Temple University Hospital and School of Medicine, Philadelphia, PA 19140, USA.
出版信息
Can J Infect Dis Med Microbiol. 2016;2016:4094932. doi: 10.1155/2016/4094932. Epub 2016 Apr 14.
Abstract
Becton Dickinson Phoenix Yeast ID Panel was compared to the Remel RapID Yeast Plus System using 150 recent clinical yeast isolates and the API 20C AUX system to resolve discrepant results. The concordance rate between the Yeast ID Panel and the RapID Yeast Plus System (without arbitration) was 93.3% with 97.3% (146/150) and 95.3% (143/150) of the isolates correctly identified by the Becton Dickinson Phoenix and the Remel RapID, respectively, with arbitration.
摘要
使用150株近期临床酵母分离株，将碧迪菲尼克斯酵母鉴定板与雷米尔快速酵母Plus系统进行比较，并使用API 20C AUX系统来解决不一致的结果。酵母鉴定板与快速酵母Plus系统（无仲裁）之间的一致率为93.3%，经仲裁后，碧迪菲尼克斯和雷米尔快速分别正确鉴定出97.3%（146/150）和95.3%（143/150）的分离株。
相似文献
1
Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification.BD Phoenix酵母鉴定板与Remel RapID Yeast Plus系统用于酵母鉴定的比较评估
Can J Infect Dis Med Microbiol. 2016;2016:4094932. doi: 10.1155/2016/4094932. Epub 2016 Apr 14.
2
[Evaluation of the BD Phoenix ID Yeast System for the Species Identification of Clinical Yeast-Like Organisms].[BD Phoenix ID酵母系统用于临床酵母样微生物菌种鉴定的评估]
Kansenshogaku Zasshi. 2017;90(6):787-91.
3
[Comparison of Phoenix™ Yeast ID Panel and API® ID 32C commercial systems for the identification of Candida species isolated from clinical samples].[用于鉴定从临床样本中分离出的念珠菌属的Phoenix™酵母鉴定板和API® ID 32C商业系统的比较]
Mikrobiyol Bul. 2014 Jul;48(3):438-48. doi: 10.5578/mb.7827.
4
Comparative performance of the RapID Yeast Plus System and the API 20C AUX Clinical Yeast System.RapID Yeast Plus系统与API 20C AUX临床酵母系统的性能比较
J Clin Microbiol. 1999 Aug;37(8):2697-8. doi: 10.1128/JCM.37.8.2697-2698.1999.
5
Comparison of BBL Crystal ANR ID Kit and API rapid ID 32 A for identification of anaerobic bacteria.用于鉴定厌氧菌的BBL Crystal ANR ID试剂盒与API快速鉴定32A的比较
Zentralbl Bakteriol. 1996 Jul;284(2-3):329-47. doi: 10.1016/s0934-8840(96)80109-5.
6
Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA Sequencing for a Wide Range of Clinically Isolated Yeast Species: Improved Identification by Combining 21-Plex PCR and API 20C AUX as an Alternative Strategy for Developing Countries.21 重聚合酶链反应与 API 20C AUX、MALDI-TOF MS 和 rDNA 测序对广泛临床分离酵母种的比较：通过将 21 重聚合酶链反应与 API 20C AUX 相结合作为发展中国家的替代策略，提高鉴定能力。
Front Cell Infect Microbiol. 2019 Feb 15;9:21. doi: 10.3389/fcimb.2019.00021. eCollection 2019.
7
8
Evaluation of the BD Phoenix SMIC/ID, a new streptococci identification and antimicrobial susceptibility panel, for potential routine use in a university-based clinical microbiology laboratory.评估BD Phoenix SMIC/ID（一种新型链球菌鉴定及抗菌药物敏感性检测板）在一所大学临床微生物学实验室用于常规检测的潜力。
Diagn Microbiol Infect Dis. 2005 Oct;53(2):101-5. doi: 10.1016/j.diagmicrobio.2005.05.016. Epub 2005 Sep 15.
9
Comparative study of seven commercial yeast identification systems.七种商业酵母鉴定系统的比较研究。
J Clin Pathol. 1999 Apr;52(4):271-3. doi: 10.1136/jcp.52.4.271.
10
Comparison of three commercial systems for identification of yeasts commonly isolated in the clinical microbiology laboratory.三种用于鉴定临床微生物实验室中常见分离酵母的商业系统的比较。
J Clin Microbiol. 1999 Jun;37(6):1967-70. doi: 10.1128/JCM.37.6.1967-1970.1999.
引用本文的文献
1
An Update on Based on Basic and Clinical Approaches.基于基础与临床方法的最新进展。 （你提供的原文“An Update on Based on Basic and Clinical Approaches.”似乎不完整，少了关键内容，以上是按大致意思翻译的）
Front Microbiol. 2017 Oct 13;8:1927. doi: 10.3389/fmicb.2017.01927. eCollection 2017.
2
Atypical Morphology and Disparate Speciation in a Case of Feline Cryptococcosis.猫隐球菌病病例中的非典型形态和不同种分化。
Mycopathologia. 2018 Apr;183(2):479-484. doi: 10.1007/s11046-017-0183-z. Epub 2017 Jul 29.
本文引用的文献
1
[Comparison of Phoenix™ Yeast ID Panel and API® ID 32C commercial systems for the identification of Candida species isolated from clinical samples].[用于鉴定从临床样本中分离出的念珠菌属的Phoenix™酵母鉴定板和API® ID 32C商业系统的比较]
Mikrobiyol Bul. 2014 Jul;48(3):438-48. doi: 10.5578/mb.7827.
2
Evaluation of the BD Phoenix system for identification of a wide spectrum of clinically important yeast species: a comparison with Vitek 2-YST.评估BD Phoenix系统对多种临床重要酵母菌种的鉴定能力：与Vitek 2-YST的比较。
Diagn Microbiol Infect Dis. 2014 Aug;79(4):477-80. doi: 10.1016/j.diagmicrobio.2014.05.011. Epub 2014 May 21.
3
Update on fungal diagnostics.真菌诊断学进展。
Curr Infect Dis Rep. 2014 Aug;16(8):415. doi: 10.1007/s11908-014-0415-z.
4
Comparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts.BD Phoenix 和 Vitek 2 系统对常见和罕见病原性酵母菌种鉴定的比较评估。
J Clin Microbiol. 2013 Nov;51(11):3841-5. doi: 10.1128/JCM.01581-13. Epub 2013 Aug 21.
5
Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility.伊曲康唑对具有降低唑类药物敏感性的新型真菌病原体 Lentulus aspergillus、Neosartorya udagawae 和 Cryptococcus gattii 的活性。
J Clin Microbiol. 2013 Sep;51(9):3090-3. doi: 10.1128/JCM.01190-13. Epub 2013 Jun 26.
6
Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.真菌血症的流行病学变化及其对抗真菌药物处方建议的潜在影响：一项全国性真菌血症监测计划的数据。
Clin Microbiol Infect. 2013 Aug;19(8):E343-53. doi: 10.1111/1469-0691.12212. Epub 2013 Apr 22.
7
Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.3648 例念珠菌血症患者的流行病学和结局：来自 2004-2008 年前瞻性抗真菌治疗（PATH 联盟）登记研究的数据。
Diagn Microbiol Infect Dis. 2012 Dec;74(4):323-31. doi: 10.1016/j.diagmicrobio.2012.10.003. Epub 2012 Oct 25.
8
Epidemiology of invasive mycoses in North America.北美洲侵袭性真菌病的流行病学。
Crit Rev Microbiol. 2010;36(1):1-53. doi: 10.3109/10408410903241444.
9
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.2019例念珠菌血症患者的流行病学及转归：来自前瞻性抗真菌治疗联盟登记处的数据
Clin Infect Dis. 2009 Jun 15;48(12):1695-703. doi: 10.1086/599039.
10
Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005.2000 - 2005年美国耐药感染住院情况的增长及地理差异
Emerg Infect Dis. 2008 Nov;14(11):1756-8. doi: 10.3201/eid1411.080337.
Zotero 插件